Impaired complement-mediated phagocytosis by HIV type-1-infected human monocyte-derived macrophages involves a cAMP-dependent mechanism

AIDS Research and Human Retroviruses

Volumn 22, Issue 7, 2006, Pages 619-629

  Azzam, Rula ^a,b,d   Kedzierska, Katherine ^c   Leeansyah, Edwin ^a,d   Chan, Hiutat ^a,b   Doischer, Daniel ^a,e   Gorry, Paul R ^a,d   Cunningham, Anthony L ^f   Crowe, Suzanne M ^a,d   Jaworowski, Anthony ^a,d,g  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF FREIBURG   (Germany)

^f UNIVERSITY OF SYDNEY   (Australia)

^g BURNET INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE INHIBITOR; COMPLEMENT; CYCLIC AMP; LAMIVUDINE; N (2 PHENYLCYCLOPENTYL)AZACYCLOTRIDECAN 2 IMINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS PATIENT; ARTICLE; BYSTANDER EFFECT; CELLULAR IMMUNITY; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE ACTIVATION; MONOCYTE; OPPORTUNISTIC INFECTION; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; SHEEP ERYTHROCYTE; VIRUS REPLICATION;

ANIMALS; CYCLIC AMP; DIDEOXYADENOSINE; DINOPROSTONE; ERYTHROCYTES; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; IMINES; MACROPHAGES; PHAGOCYTOSIS; RECEPTORS, COMPLEMENT; SHEEP; VIRUS REPLICATION;

EID: 33745947008     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.22.619     Document Type: Article

References (74)

1. Kedzierska K, Azzam R, Ellery P, Mak J, Jaworowski A, and Crowe S: Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: Underlying mechanisms and modulation by adjunctive cytokine therapy. J Clin Virol 2003;26:247-263.
2. Crowe SM, Vardaxis NJ, Kent SJ, et al.: HIV infection of monocyte-derived macrophages in vitro reduces phagocytosis of Candida albicans. J Leukoc Biol 1994;56:318-327.
3. Biggs BA, Hewish M, Kent S, Hayes K, and Crowe SM: HIV-1 infection of human macrophages impairs phagocytosis and killing of Toxoplasma gondii. J Immunol 1995;154:6132-6139.
4. Thomas CA, Weinberger OK, Ziegler BL, et al.: Human immunodeficiency virus-1 env impairs Fc receptor-mediated phagocytosis via a cyclic adenosine monophosphate-dependent mechanism. Blood 1997;90:3760-3765.
5. Kedzierska K, Mak J, Mijch A, et al.: Granulocyte-macrophage colony-stimulating factor augments phagocytosis of Mycobacterium avium complex by human immunodeficiency virus type 1-infected monocytes/macrophages in vitro and in vivo. J Infect Dis 2000;181:390-394.
6. Kedzierska K, Mak J, Jaworowski A, et al.: nef-deleted HIV-1 inhibits phagocytosis by monocyte-derived macrophages in vitro but not by peripheral blood monocytes in vivo. AIDS 2001;15: 945-955.
7. Kedzierska K, Ellery P, Mak J, Lewin S, Crowe SM, and Jaworowski A: HIV-1 downmodulates gamma signaling chain of Fc-gamma receptor in human macrophages: A possible mechanism for inhibition of phagocytosis. J Immunol 2002;168:2895-2903.
8. Capsoni F, Minonzio F, Ongari AM, et al.: Fc receptors expression and function in mononuclear phagocytes from AIDS patients; modulation by IFN-gamma. Scand J Immunol 1994;39:45-50.
9. Chaturvedi S, Frame P, and Newman SL: Macrophages from human immunodeficiency virus positive persons are defective in host defence against Histoplasma capsulation. J Infect Dis 1995;171: 320-327.
10. Aderem A and Underbill D: Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 1999;17:593-623.
11. Buyon J, Slade S, Reibman J, et al.: Constitutive and induced phosphorylation of the alpha- and beta-chains of the CD11/CD18 leukocyte integrin family. Relationship to adhesion-dependent functions. J Immunol 1990;144:191-197.
12. Chatila T, Geha R, and Arnaout M: Constitutive and stimulus-induced phosphorylation of CD11/CD18 leukocyte adhesion molecules. J Cell Biol 1989;109:3435-3444.
13. Fagerholm S, Morrice N, Gahmberg CG, and Cohen P: Phosphorylation of the cytoplasmic domain of the integrin CD18 chain by protein kinase C isoforms in leukocytes. J Biol Chem 2002;277:1728-1738.
14. Zhou X and Li J: Macrophage-enriched myristoylated alanine-rich C kinase substrate and its phosphorylation is required for the phorbol ester-stimulated diffusion of beta 2 integrin molecules. J Biol Chem 2000;275:20217-20222.
15. Calderwood D, Shattil S, and Ginsberg M: Integrins and actin filaments: Reciprocal regulation of cell adhesion and signaling. J Biol Chem 2000;275:22607-22610.
16. Sampath R, Gallagher P, and Pavalkos F: Cytoskeletal interactions with the leukocyte integrin β2 cytoplasmic tail. J Biol Chem 1998;273:33588-33594.
17. Wright S and Meyer B: Phorbol esters cause sequential activation and deactivation of complement receptors on polymorphonuclear leukocytes. J Immunol 1986;136:1759-1764.
18. Berton G and Lowell C: Integrin signalling in neutrophils and macrophages. Cell Signal 1999;11:621-635.
19. Caron E and Hall A: Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 1998;282:1717-1721.
20. Schoenwalder S and Burridge K: Bidirectional signaling between the cytoskeleton and integrins. Curr Opin Cell Biol 1999;11:274-286.
21. Chimini G and Chavrier P: Function of Rho family proteins in actin dynamics during phagocytosis and engulfment. Nat Cell Biol 2000;2:E191-196.
22. Antoni F: The molecular diversity of cyclic AMP signalling. Front Neuroendocrinol 2000;21:103-132.
23. Laudanna C, Campbell JJ, and Butcher EC: Elevation of intracellular cAMP inhibits RhoA activation and integrin-dependent leukocyte adhesion induced by chemoattractants. J Biol Chem 1997;272: 24141-24144.
24. Lang P, Gesbert F, Delespinecarmagnat M, Stancou R, Pouchelet M, and Bertoglio J: Protein kinase A phosphorylation of RhoA mediated the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes. EMBO J 1996;15:510-519.
25. Busca R, Bertolotto C, Abbe P, et al.: Inhibition of Rho is required for cAMP-induced melanoma cell differentiation. Mol Biol Cell 1998;9:1367-1378.
26. Dong J, Leung T, Manser E, and Lim L: cAMP-induced morphological changes are counteracted by the activated Rhoa small GTPase and the Rho kinase ROK-alpha. J Biol Chem 1998;273:22554-22562.
27. Chan H, Kedzierska K, O'Mullane J, Crowe SM, and Jaworowski A: Quantifying complement-mediated phagocytosis by human monocyte-derived macrophages. Immunol Cell Biol 2001;79: 429-435.
28. Kedzierska K and Crowe SM. Culture of HIV in monocytes and macrophages. In: Current Protocols in Immunology. Greene Publishing Associates, Inc. and John Wiley & Sons, Inc., New York, 2001, p. 12.14.11.
29. Gebran SJ, Romano EL, Pons HA, Cariani L, and Soyano AN: A modified colorimetric method for the measurement of phagocytosis and antibody-dependent cell cytotoxicity using 2,7-diaminofluorene. J Immunol Methods 1992;151:255-260.
30. Nokta M and Pollard R: Human immunodeficiency virus infection: Association with altered intracellular levels of cAMP and cGMP in MT-1 cells. Virology 1991;181:211-217.
31. Hofmann B, Parunag N, Nguyen T, Praphaphone I, and Fahey J: Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes. Proc Natl Acad Sci USA 1993;90:6676-6680.
32. Newman SL, Mikus LK, and Tucci MA: Differential requirements for cellular cytoskeleton in human macrophage complement receptor-and Fc receptor-mediated phagocytosis. J Immunol 1991; 146:967-974.
33. Rossi AG, McCutcheon JC, Roy N, Chilvers ER, Haslett C, and Dransfield I: Regulation of macrophage phagocytosis of apoptotic cells by cAMP. J Immunol 1998;160:3562-3568.
34. Zalavary S, Stendahl O, and Bengtsson T: The role of cyclic AMP, calcium and filamentous actin in adenosine modulation of Fc receptor-mediated phagocytosis in human neutrophils. Biochim Biophys Acta 1994;1222:249-256.
35. Foley P, Kazazi F, Biti R, Sorrell T, and Cunningham A: HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids. Immunology 1992;75:391-397.
36. Mastino A, Grelli S, Piacentini M, et al.: Correlation between induction of lymphocyte apoptosis and prostaglandin E2 production by macrophages infected with HIV. Cell Immunol 1993;152: 120-130.
37. 2 inhibits replication of HIV-1 in macrophages through activation of protein kinase A. Cell Immunol 2002;215:61-71.
38. Griffin DE, Wesselingh SL, and McArthur JC: Elevated central nervous system prostaglandins in human immunodeficiency virus associated dementia. Ann Neurol 1994;35:592-597.
39. Delemarre F, Stevenhagen A, Kroon F, van Eer M, Meenhorst P, and Furth R: Reduced toxoplasmastatic activity of monocyts and monocyte-derived macrophages from AIDS patients is mediated via prostaglandin E2. AIDS 1995;9:441-445.
40. Coleman R, Smith W, and Narumiya S: International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994;46:205-229.
41. Di Marzio P, Tse J, and Landau NR: Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophages. AIDS Res Hum Retroviruses 1998;14:129-138.
42. Bender B, Davidson B, Kline R, Brown C, and Quinn T: Role of the mononuclear phagocyte system in the immunopathogenesis of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Rev Infect Dis 1988;10:1142-1154.
43. Petit AJC, Terpstra FG, and Miedema F: Human immunodeficiency virus infection down-regulates HLA class II expression and induces differentiation in promonocytic U937 cells. J Clin Invest 1987;79: 1883-1889.
44. Palmer S and Hamblin AS: Increased CD11/CD18 expression on the peripheral blood leucocytes of patients with HIV disease: Relationship to disease severity. Clin Exp Immunol 1993;93:344-349.
45. Stent G, Cameron PU, and Crowe SM: Expression of CD11/CD18 and ICAM-1 on monocytes and lymphocytes of HIV-1 infected individuals. J Leukoc Biol 1994;56:304-309.
46. Kent SJ, Stent G, Sonza S, Hunter SD, and Crowe SM: HIV-1 infection of monocyte-derived macrophages reduces Fc and complement receptor expression. Clin Exp Immunol 1994;95:450-454.
47. Eppell BA, Newell AM, and Brown EJ: Adenosine receptors are expressed during differentiation of monocytes to macrophages in vitro. Implications for regulation of phagocytosis. J Immunol 1989;143:4141-4145.
48. Fallman M, Lew DP, Stendahl O, and Andersson T: Receptor-mediated phagocytosis in human neutrophils is associated with increased formation of inositol phosphates and diacylglycerol. Elevation in cytosolic free calcium and formation of inositol phosphates can be dissociated from accumulation of diacylglycerol. J Clin Invest 1989;84:886-891.
49. Andersson T, Fallman M, Lew DP, and Stendahl O: Does protein kinase C control receptor-mediated phagocytosis in human neutrophils? FEBS Lett 1988;239:371-375.
50. Maekawa M, Ishizaki T, Boku S, et al.: Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 1999;285:895-898.
51. Bishop A and Hall A: Rho GTPases and their effector proteins. Biochem J 2000;348:241-255.
52. Lutz M and Correll P: Activation of CR3-mediated phagocytosis by MSP requires the RON receptor, tyrosine kinase activity, phosphatidylinositol 3-kinase, and protein kinase C zeta. J Leukoc Biol 2003;73:802-814.
53. Wang L, Liu F, and Adamo M: Cyclic AMP inhibits extracellular signal-regulated kinase and phosphatidylinositol 3-kinase/Akt pathways by inhibiting Rap1. J Biol Chem 2001;276:37242-37249.
54. Cristillo A, Highbarger H, Dewar R, Dimitrov D, Golding H, and Bierer B: Up-regulation of HIV coreceptor CXCR4 expression in human T lymphocytes is mediated in part by a cAMP-responsive element. FASEB J 2002;16:354-364.
55. Thivierge M, Le Gouill C, Tremblay M, Stankova J, and Rola-Pleszczynski M: Prostaglandin E2 induces resistance to human immunodeficiency virus-1 infection in monocyte-derived macrophages: Downregulation of CCR5 expression by cyclic adenosine monophosphate. Blood 1998;92:40-45.
56. Banas B, Eberle J, Banas B, Schlondorff D, and Luckow B: Modulation of HIV-1 enhancer activity and virus production by cAMP. FEBS Lett 2001;509:207-212.
57. Rabbi M, Al-Harthi L, and Roebuck K: TNFalpha cooperates with the protein kinase A pathway to synergistically increase HIV-1 LTR transcription via downstream TRE-like cAMP response elements. Virology 1997;237:422-429.
58. Cartier C, Hemonnot B, Gay B, et al.: Active cAMP-dependent protein kinase incorporated within highly purified HIV-1 particles is required for viral infectivity and interacts with viral capsid protein. J Biol Chem 2003;278:35211-35219.
59. Hofmann B, Nishanian P, Nguyen T, Liu M, and Fahey J: Restoration of T-cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues. AIDS 1993;7:659-664.
60. Bourne H, Lichtenstein L, Melmon K, Henney C, Weinstein Y, and Shearer GM: Modulation of inflammation and immunity by cyclic AMP. Science 1974;184:19-28.
61. Murray A, Froscio M, and Kemp BE: Histone phosphatase and cyclic nucleotide-stimulated protein kinase from human lymphocytes. Biochem J 1972;129:995-1002.
62. Kemp B, Froscio M, Rogers A, and Murray A: Multiple protein kinases from human lymphocytes. Identification enzymes phosphorylating exogenous histon and casein. Biochem J 1975;145: 241-249.
63. Heidenreich S, Otte B, Lang D, and Schmidt M: Infection by Candida albicans inhibits apoptosis of human monocytes and monocytic U937 cells. J Leukoc Biol 1996;60:737-743.
64. von Knethen A and Brune B: Attenuation of macrophage apoptosis by the cAMP-signaling system. Mol Cell Biochem 2000;212:35-43.
65. von Knethen A, Brockhaus F, Kleiter I, and Brune B: NO-Evoked macrophage apoptosis is attenuated by cAMP-induced gene expression. Mol Med 1999;5:672-684.
66. Fine J, Byrnes H, Zavodny P, and Hipkin R: Evaluation of signal transduction pathways in chemoattractant-induced human monocyte chemotaxis. Inflammation 2001;25:61-67.
67. Stephens C and Snyderman R: Cyclic nucleotides regulate the morphologic alterations required for chemotaxis in monocytes. J Immunol 1982;128:1192-1197.
68. Munoz E, Zubiaga A, Merrow M, Sauter N, and Huber B: Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: Role of cAMP in T cell proliferation. J Exp Med 1990;172:95-103.
69. Gajewski T, Schell S, and Fitch F: Evidence implicating utilization of different T cell receptor-associated signaling pathways by TH1 and TH2 clones. J Immunol 1990;144:4110-4120.
70. Schandene L, Vandenbussche P, Crusiaux A, et al.: Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells. Immunology 1992;76:30-34.
71. Thanhauser A, Reiling N, Bohle A, et al.: Pentoxifylline: A potent inhibitor of IL-2 and IFN-gamma biosynthesis and BCG-induced cytotoxicity. Immunology 1993;80:151-156.
72. Lacour M, Arrighi J, Muller K, Carlberg C, Saurat J, and Hauser C: cAMP up-regulates IL-4 and IL-5 production from activated CD4+ T cells while decreasing IL-2 release and NF-AT induction. Int Immunol 1994;6:1333-1343.
73. Lucey D, Clerici M, and Shearer G: Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 1996;9:532-562.
74. Kedzierska K and Crowe SM: Cytokines and HIV-1: Interactions and clinical implications. Antiviral Chem Chemother 2001;12:133-145.